Esophageal candidiasis: Difference between revisions

Line 13: Line 13:


==Evaluation==
==Evaluation==
[[File:Oral Candidiasis.jpg|thumb|Esophageal Candidiasis]]
[[File:Oral Candidiasis.jpg|thumb|Esophageal candidiasis]]
*Thick, white, linear esophageal plaques on endoscopy  
*Thick, white, linear esophageal plaques on endoscopy


==Management==
==Management==

Revision as of 20:37, 16 November 2022

Background

  • Most commonly seen in HIV patients with CD4 count < 100 (AIDS-defining illness) or chronic inhaled glucocorticoid use

Clinical Features[1]

Differential Diagnosis

Esophagitis Types

HIV associated conditions

Evaluation

Esophageal candidiasis
  • Thick, white, linear esophageal plaques on endoscopy

Management

  • Fluconazole 400mg PO loading dose, followed by 200mg PO Qdaily x 2 weeks
  • Itraconazole 200mg PO Qdaily for 2 weeks
    • has more nausea side-effects and drug interactions compared to fluconazole

Disposition

  • Depends on ability to tolerate oral solids and liquids. Most patients will be dispositioned home with outpatient followup.

See Also

External Links

References

  1. Kauffmann CA. Overview of Candida Infections. UptoDate. 2016.
  2. Gutteridge, David L MD, MPH, Egan, Daniel J. MD. The HIV-Infected Adult Patient in The Emergency Department: The Changing Landscape of the Disease. Emergency Medicine Practice: An Evidence-Based Approach to Emergency Medicine. Vol 18, Num 2. Feb 2016.